Program

Reception desk / Imagine entrance

Oral presentations / auditorium

Poster presentations / 7th floor

Coffee and lunch breaks / 6th floor

    • 9:00 AM Corentin Le Floc'h

      Autosomal dominant ZAP70 deficiency

    • 9:15 AM Juan Eduardo Montero-Hernández

      CCL2 chemokine follows a complex bi-temporal secretion pattern for local attraction during IgE-mediated mast cell activation

    • 9:30 AM Marco M Rodari

      Human integrin alpha-V deficiency skews B cell responses toward extra-follicular pathways in IgE-mediated allergy

    • 9:45 AM Aldevron

    • 10:00 AM Lea Nabhan

      A genome-wide CRISPR interference (CRISPRi) screen to identify essential V(D)J/DNA repair genes

    • 10:15 AM Boris Bessot

      Gene therapy for Artemis-SCID patients: preliminary results of the French ARTEGENE phase I/II clinical trial

Coffee break / 30 minutes

    • 11:00 AM Christin Weissleder

      Parkinson’s Disease and the Gut-Brain Axis: How Microbial Metabolites and Genetic Risk Drive Immune Cell Dysfunction

    • 11:15 AM Zoéline Mars

      DDX41, a gene associated with predisposition to hematological malignancies, is responsible for syndromic retinal dystrophy

    • 11:30 AM Joran Martin

      Primary cilium drives inflammatory response associated with uropathogenic bacteria infection and kidney obstruction damage

    • 11:45 AM ProteinTech

    • 12:00 AM Bianca Ionela Slivinschi

      A novel iPSC-derived Gut-on-Chip model for studying Parkinson’s Disease pathology

    • 12:15 AM Joël Boivin

      Generation of new zebrafish models via precise genome editing

Lunch break / 12:30 PM - 01:30 PM

    • 01:30 PM Lucile Marchal

      Multi-omic analysis of cutaneous squamous cell carcinoma in patients with Recessive Dystrophic Epidermolysis Bullosa identifies new therapeutic targets

    • 01:45 PM Romain Nicolle

      Graph neural networks reveal digenic disease candidates through biological network analysis

    • 02:00 PM Adrien Schvartz

      Specific Transcriptomic Signature in Oligoarticular JIA Patients Who Will Not Respond to Anti-TNFα Treatment

Coffee break / 30 minutes

    • Florence Gazeau
      Research Director at NABI Laboratory, UPC - CNRS